Navigation Links
Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
Date:8/19/2007

Interim Phase 1 Data Confirms Safety and Tolerability

PLYMOUTH MEETING, Pa., Aug. 8 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today announced interim data from the first Phase 1 clinical study of trodusquemine (MSI-1436) for the treatment of obesity. Anthony DelConte, M.D., Vice President, Clinical Research and Development, presented "Trodusquemine: A Novel Aminosterol for the Treatment of Obesity and Related Metabolic Disorders," during the IBC 12th Annual World Congress on Drug Discovery & Development of Innovative Therapeutics, August 6-8 in Boston.

The presentation summarized the clinical trial design of the single ascending dose Phase 1 study of MSI-1436 to evaluate safety and pharmacokinetics of the drug in healthy obese volunteers. Dr. DelConte provided interim data from the initial cohorts in the double-blind, randomized, placebo-controlled trial which included safety and pharmacokinetic (PK) data from 20 treated subjects and eight vehicle controls in four sequential dose groups. According to Dr. DelConte, PK profiles from the study thus far show a predictable pattern with minimal subject-to-subject variability and linearity across the range of doses studied. To date, no serious adverse events have been reported. It was emphasized that further study is needed to establish dose limiting toxicity and proof-of-concept in humans.

"These initial findings validate the preclinical safety and PK work done by Genaera scientists. We are encouraged by these findings and will continue to further characterize the safety profile and provide proof of concept for trodusquemine in obesity and type 2 diabetes management," commented Jack Armstrong, President and CEO. "We anticipate a
'/>"/>

SOURCE Genaera Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
2. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
3. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
4. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
5. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
6. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
7. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 ... announced the addition of the "North American ... Graft), by Application (Surgical Wound, & Ulcer), by ... to 2019" report to their offering. ,     ... care market is estimated to grow at a ...
(Date:5/21/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today that its Board of ... second quarter 2015 of $0.03 per share of common ... share will be paid on June 19, 2015 to ... 2015.  The ex-dividend date for the quarterly dividend is ...
(Date:5/21/2015)... , May 21, 2015 The ... statement regarding the Medicare Part D offsets included ... Cures initiative: "If the 21st Century Cures ... from America,s premier health program – Medicare – ... may yield down the road. "Leveraging ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2
... Inc. (Nasdaq: DCTH ) announced today that it has ... common stock at $3.60 per share, or $30.6 million, pursuant ... the Company has granted the underwriters of the offering an ... primary stock to cover over-allotments. The offering is expected ...
... NEW YORK, Nov. 12 Reportlinker.com announces ... available in its catalogue. , ... to 2015 , ... Market Analysis & Forecasts to 2015 , ...
Cached Medicine Technology:Delcath Systems, Inc. Prices $30.6 Million Stock Offering 2Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 2Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 3Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 4Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 5Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 6Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 7Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 8Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 9Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 10Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 11Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 12Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 13Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 14Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 15Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 16Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015 17
(Date:5/22/2015)... 2015 Power Systems is proud to announce ... race season. Drobeck is in his second year of racing ... with the Missoula Fire Department in Missoula, MT. He entered ... 2014. During his career, he has had 15 1st Place ... top 10 finishes in all seven of his 2014 races, ...
(Date:5/22/2015)... PA (PRWEB) May 22, 2015 According to ... a hub for drug related death, totaling almost 2,500 confirmed ... as reported by state officials, totals 2,489 deaths stemming from ... work out, Pennsylvania loses seven people every day to fatal ... has been singled out as one of the most rife ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Medivo, Inc., a ... “Positivity Rates and Genotype Results in ‘Baby Boomers’ Screened for ... a Nationwide Lab Test Database” at Digestive Disease Week, May ... Clinical Affairs and Analytics team members Carol Smyth, MB; Jason ... Andrea Parker, MSI, along with Nancy Reau, MD from the ...
(Date:5/22/2015)... 22, 2015 Wimbledon Health Partners, the ... (EKG), echocardiogram and NCV testing , is proud ... respected All American National athlete, to the Wimbledon Athletics ... the high level of testing and information it provides ... their athletic trainers, this way they can focus on ...
(Date:5/22/2015)... Phoenix, AZ (PRWEB) May 22, 2015 ... Special Olympics, Parker and Sons is offering to donate ... for installing an AC unit or water softening system. ... their behalf; Parker and Sons gets business; and the ... , The Special Olympics helps over 4.4 million ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... May 23, 2011 -- The next agricultural revolution may ... the growing needs of the planet without the need for ... the 111th General Meeting of the American Society for Microbiology ... by the year 2050 the global human population is expected ...
... MONDAY, May 23 (HealthDay News) -- Cancer patients who are ... sense of satisfaction about their treatment, a new study finds. ... accurate medical information built trust between patient and doctor. ... the study analyzed 295 patients recently diagnosed with lymphoma, breast ...
... is a very common complaint, with over 90% of ... their lives. Headaches commonly are tension-type (TTH) or migraine. ... daily activities. Treatments range from pharmacologic to behavioral interventions. ... Journal of Manipulative and Physiological Therapeutics, a group ...
... Children,s Hospital Boston and collaborators at other institutions has ... cells produce new bone in response to mechanical stresses, ... developing new strategies for treating diseases characterized by low ... imperfecta in children. The research team, led by ...
... , SATURDAY, May 21 (HealthDay News) -- Football players ... they hit the training field in August, an expert ... and other potentially serious heat-related injuries, according to Dr. ... Medicine in Houston. Heat-related illnesses have claimed the ...
... Georgetown University Medical Center,s Howard J. Federoff, MD, ... along with advocates, at the "One Mind for Research ... understanding and treatment of brain disorders. By uniting ... new 10-year research agenda for the field of neuroscience. ...
Cached Medicine News:Health News:Fungi reduce need for fertilizer in agriculture 2Health News:Cancer Patients Benefit From Full Access to Medical Records 2Health News:Substantial recovery rate with placebo effect in headache treatment 2Health News:A direct path for understanding and treating brittle bones 2Health News:A direct path for understanding and treating brittle bones 3Health News:Football Players Urged to Beat the Heat 2Health News:'The Potential to Modify the Course of Parkinson's Disease' 2
2.0mm Rounded Tip, 12mm From Tip to Bend Gently Curved, 15mm Shaft; In Titanium...
Angled 40 Degrees, 0.6x0.8 Elliptical Tip; in Titanium...
0.5X2.0mm Tip, Oval Shape; in Titanium....
30 Degree Angle Shaft with 1.0mm 90 Degree Angle Tip; in stainless steel....
Medicine Products: